Mode of action of antituberculous agents and ultrastructure of mycobacteria.
D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D003523:Cycloserine / Q000494:pharmacology; D004977:Ethambutol / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology / Q000627:therapeutic use; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008854:Microscopy, Electron; D009169:Mycobacterium tuberculosis / Q000166:cytology / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D007538:Isoniazid; D012293:Rifampin